MedTrace Logo

AVocAdo Extract to Improve gLycemia in Individuals With Obesity (AVAIL)

NCT04763473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-04-10

No results posted yet for this study

Summary

This two-arm, double blind, randomized clinical trial will compare the effect of an avocado extract, compared to placebo, on cardiometabolic outcomes in adults with obesity.

Conditions

Interventions

DIETARY_SUPPLEMENT

Avocado extract

Participants will consume 10 grams of freeze dried avocado daily for 12 weeks.

DIETARY_SUPPLEMENT

Placebo

Participants will consume 10 grams of corn meal daily for 12 weeks.

Sponsors & Collaborators

  • Isagenix International LLC

    collaborator INDUSTRY

  • Commonwealth Scientific and Industrial Research Organisation, Australia

    collaborator OTHER_GOV

  • Prolongevity Technologies

    collaborator INDUSTRY

  • University of Adelaide

    lead OTHER

Principal Investigators

  • Leonie Heilbronn · The University of Adelaide

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-09
Primary Completion
2022-08-11
Completion
2022-08-11

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04763473 on ClinicalTrials.gov